Global Narcolepsy Market Size
The market for narcolepsy was valued at US$ 1.797 billion in 2020 and is projected to grow at a compound annual growth rate (CAGR) of 8.9% to reach US$ 4.205 billion by 2030.
Unplanned sleep episodes and excessive everyday tiredness characterize the medical condition known as narcolepsy. This persistent sleep disorder may result in an abrupt decrease of muscular tone (cataplexy), which can cause weakness and a loss of motor control. Sleep paralysis, hallucinations, daytime sleepiness, fragmented sleep, and insomnia are some of the most common symptoms of the illness. Cataplexy is a rapid muscle strength decrease affecting about 70% of people. It has been demonstrated to affect patients' mental well-being significantly. Moving immobility or experiencing intense hallucinations are possible during sleep or wakefulness. Although they sleep for roughly the same amount of hours each day as those without narcolepsy, those who have the condition sleep less well. Narcolepsy is a chronic illness that is uncommon and underdiagnosed; many sufferers worldwide remain unidentified.
The COVID-19 pandemic's effects on the market
The increasing availability of animal models has made it possible for researchers to gain a deeper understanding of the intricacy of the brain, particularly the functional relationship between the brain and sleep. As a result, the neurobiology of sleep has advanced dramatically in recent decades. The novel coronavirus is causing severe respiratory distress, and in many of the cases reported so far, severe respiratory failure has been the primary cause of death.